All Stories

  1. Lessons learned for the Independent Panel for Evidence for Action against AMR from previous international science panels: stakeholder views from the 2025 Lagos Workshop
  2. Age distribution of typhoid fever, paratyphoid fever, and non-typhoidal Salmonella invasive disease: a secondary analysis of global epidemiologic data
  3. Enteroaggregative Escherichia clade I from Nigeria
  4. Refining the Serine Protease Autotransporters of Enterobacteriaceae (SPATE) gene detection in Enteroaggregative Escherichia coli genomes uncovers differential SPATE distribution by phylogeny
  5. Identification of Antibiofilm Agents against Salmonella enterica from the Pathogen Box Compound Library
  6. Genomic characterization of resistant Escherichia coli isolated from household water in municipal Ibadan, Nigeria
  7. Knowledge, Attitudes, and Perceptions Surrounding Antibiotic Use: Exploring Social Determinants of Antibiotic Misuse in Peri-Urban Nigeria
  8. Community-led Strategies for Ameliorating Antimicrobial Resistance in Nigeria:  Research Protocol for a Participatory Action Research Project
  9. Stakeholder Views on Lessons Learned for the Antimicrobial Resistance Panel from Previous International Science Panels
  10. Genomic epidemiology of enteropathogenic Escherichia coli in southwestern Nigeria
  11. Barriers and facilitators to digital technology application for antimicrobial resistance surveillance: A co-produced qualitative synthesis
  12. Slow-growing Salmonella enterica serovariety Typhi mis-identified as serovariety Gallinarum in Ibadan, Nigeria
  13. Transmissible antimicrobial resistance in Escherichia coli isolated from household drinking water in Ibadan, Nigeria
  14. Case Report: Detection of invasive mcr-10 harbouring Klebsiella quasipneumoniae subsp. similipneumoniae in a patient with chronic myeloid leukaemia.
  15. Beyond high cost: Pharmaceutic low-resource setting barriers to antibacterial access
  16. Decentralising Bioinformatics Capacity: Lessons from Training Hospital Staff and Field Epidemiologists in Nigeria
  17. Genomic epidemiology of enteropathogenic Escherichia coli(EPEC) in southwestern Nigeria
  18. Genomic characterization of foodborne Salmonella enterica and Escherichia coli isolates from Saboba district and Bolgatanga Municipality Ghana
  19. Transmissible antimicrobial resistance in Escherichia coli isolated from household drinking water in Ibadan, Nigeria
  20. Insights of SEDRIC, the Surveillance and Epidemiology of Drug-Resistant Infections Consortium
  21. Barriers and Facilitators to Digital Technology Application for Antimicrobial Resistance Surveillance: A Co-Produced Qualitative Synthesis
  22. Slow-growingSalmonella entericaTyphi mis-identified asSalmonellaGallinarum in Ibadan, Nigeria
  23. Genetic basis for antimicrobial resistance inEscherichia coliisolated from household water in municipal Ibadan, Nigeria
  24. Whole Genome Sequencing RevealsEnterobacter hormaecheias a Key Bloodstream Pathogen in Six Tertiary Care Hospitals in Southwestern Nigeria
  25. Occurrence of Salmonella enterica in faecal sludge from Nigeria and genetic relatedness with strains associated with human infections in Africa
  26. A Systematic Review of Antibiotic Use in Humans in Nigeria and its Potential Contribution to Rising Antimicrobial Resistance
  27. A Systematic Review of Antibiotic Use in Humans in Nigeria and its Potential Contribution to Rising Antimicrobial Resistance
  28. NDM-1- and OXA-23-producing Acinetobacter baumannii in wastewater of a Nigerian hospital
  29. PCR diagnostics are insufficient for the detection of Diarrhoeagenic Escherichia coli in Ibadan, Nigeria
  30. Evaluation of fecal occult blood testing for rapid diagnosis of invasive diarrhea in young children
  31. Prevalence and whole genome phylogenetic analysis reveal genetic relatedness between antibiotic resistance Salmonella in hatchlings and older chickens from farms in Nigeria
  32. Evaluation of Fecal Occult Blood Testing Kits for Rapid Point-of-Care Diagnosis of Invasive Diarrhea in Young Children
  33. Insufficiency of PCR diagnostics for Detection of DiarrhoeagenicEscherichia coliin Ibadan, Nigeria
  34. Antibiofilm agents with therapeutic potential against enteroaggregative Escherichia coli
  35. Epidemiology and risk factors for diarrhoeagenic Escherichia coli carriage among children in northern Ibadan, Nigeria
  36. Establishing a national reference laboratory for antimicrobial resistance using a whole-genome sequencing framework: Nigeria’s experience
  37. Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria
  38. A bottom-up view of antimicrobial resistance transmission in developing countries
  39. Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria
  40. Towards a fiercely urgent expansion of laboratory medicine in Africa
  41. Antibiofilm agents with therapeutic potential against enteroaggregative Escherichia coli
  42. Twenty steps to ingrain power asymmetry in global health biomedical research
  43. The importance of molecular diagnostics for infectious diseases in low-resource settings
  44. Bacteria autoaggregation: how and why bacteria stick together
  45. Genomic Analysis of Antimicrobial Resistance and Resistance Plasmids in Salmonella Serovars from Poultry in Nigeria
  46. African laboratory medicine in the time of COVID-19
  47. A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants
  48. A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants
  49. Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings
  50. A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants
  51. Editorial overview: Paths of least resistance: surveillance, discovery, and innovation to address the other (antimicrobial resistance) pandemic
  52. A plasmid-encoded papB paralogue modulates autoaggregation of Escherichia coli transconjugants
  53. The Not so Good, the Bad and the Ugly: Differential Bacterial Adhesion and Invasion Mediated by Salmonella PagN Allelic Variants
  54. Extending the breadth of African laboratory medicine
  55. A large self-transmissible resistance plasmid from Nigeria contains genes that ameliorate a carrying cost
  56. Quality assessment of bacterial identification and antimicrobial susceptibility testing in African national health laboratories, 2011 - 2016
  57. A large self-transmissible plasmid from Nigeria confers resistance to multiple antibacterials without a carrying cost
  58. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis
  59. Antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa: A systematic review
  60. Antimicrobial resistance surveillance in Africa: Successes, gaps and a roadmap for the future
  61. Building resources to meet evolving laboratory medicine challenges in Africa
  62. Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action
  63. Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action
  64. Interplay of surface factors in colonization by a diarrhea pathogen
  65. Enteroaggregative Escherichia coli Have Evolved Independently as Distinct Complexes within the E. coli Population with Varying Ability to Cause Disease
  66. Dissemination of the Transmissible Quinolone-Resistance Gene qnrS1 by IncX Plasmids in Nigeria
  67. Diagnostic schemes for reducing epidemic size of african viral hemorrhagic fever outbreaks
  68. Comparative genomics of 274 Vibrio cholerae genomes reveals mobile functions structuring three niche dimensions
  69. Cholera Outbreaks in Nigeria Are Associated with Multidrug Resistant Atypical El Tor and Non-O1/Non-O139 Vibrio cholerae
  70. Regional Dissemination of a Trimethoprim-Resistance Gene Cassette via a Successful Transposable Element
  71. Vibrio cholerae O1 lineages driving cholera outbreaks during seventh cholera pandemic in Ghana
  72. Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use
  73. Non-prescription antimicrobial use worldwide: a systematic review
  74. The Heat-Resistant Agglutinin Family Includes a Novel Adhesin from Enteroaggregative Escherichia coli Strain 60A
  75. Diagnostics as essential tools for containing antibacterial resistance
  76. Ensuring Global Access to Quality Medicines: Role of the US Pharmacopeia
  77. IS3 profiling identifies the enterohaemorrhagic Escherichia coli O-island 62 in a distinct enteroaggregative E. coli lineage
  78. Quinolone resistance in Escherichia coli from Accra, Ghana
  79. Multi-Locus Sequence Typing of Enteroaggregative Escherichia coli Isolates from Nigerian Children Uncovers Multiple Lineages
  80. Carriage of diarrhoeagenic Escherichia coli by older children and adults in Accra, Ghana
  81. A Pathoadaptive Deletion in an Enteroaggregative Escherichia coli Outbreak Strain Enhances Virulence in a Caenorhabditis elegans Model
  82. African Researchers Underrepresented
  83. Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil
  84. Cholera Vaccine Will Reduce Antibiotic Use
  85. Heat-Resistant Agglutinin 1 Is an Accessory Enteroaggregative Escherichia coli Colonization Factor
  86. The Escherichia coli Common Pilus and the Bundle-Forming Pilus Act in Concert during the Formation of Localized Adherence by Enteropathogenic E. coli
  87. The commonly-used DNA probe for diffusely-adherent Escherichia coli cross-reacts with a subset of enteroaggregative E. coli
  88. The Plasmid-Encoded Regulator Activates Factors Conferring Lysozyme Resistance on Enteropathogenic Escherichia coli Strains
  89. Post-genomic challenges for collaborative research in infectious diseases
  90. Vibrio cholerae O1 from Accra, Ghana carrying a class 2 integron and the SXT element
  91. Connecting loose ends: a unique linear plasmid or a new model system?
  92. Growing Problem of Multidrug-Resistant Enteric Pathogens in Africa
  93. A Second Large Plasmid Encodes Conjugative Transfer and Antimicrobial Resistance in O119:H2 and Some Typical O111 Enteropathogenic Escherichia coli Strains
  94. EnteroaggregativeEscherichia coliRelated to Uropathogenic Clonal Group A
  95. Error-Prone DNA Repair System in Enteroaggregative Escherichia coli Identified by Subtractive Hybridization
  96. Diagnostic Insufficiency in Africa
  97. Antimicrobial resistance in developing countries. Part II: strategies for containment
  98. Antimicrobial resistance in developing countries. Part I: recent trends and current status
  99. Stopping the Spread of Drug-Resistant Malaria
  100. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries
  101. Molecular Epidemiology of the Iron Utilization Genes of Enteroaggregative Escherichia coli
  102. Etiology of Acute Diarrhea in Adults in Southwestern Nigeria
  103. Antibiotic-Resistant Cell-Detaching Escherichia coli Strains from Nigerian Children
  104. Enteroaggregative Escherichia coli
  105. Bacteriological quality of skin-moisturizing creams and lotions distributed in a tropical developing country
  106. Comparative Sequence Analysis of the Plasmid-Encoded Regulator of Enteropathogenic Escherichia coliStrains
  107. Microbiological investigation of an outbreak of acute gastroenteritis in Niger State, Nigeria
  108. Dissemination of Antibiotic‐Resistant Bacteria across Geographic Borders
  109. espC Pathogenicity Island of Enteropathogenic Escherichia coli Encodes an Enterotoxin
  110. Antibiotic Resistance in Escherichia coli from Nigerian Students, 1986-1998
  111. Heterogeneous Virulence of EnteroaggregativeEscherichia coliStrains Isolated from Children in Southwest Nigeria
  112. Antimicrobial spectrum ofAlchornea cordifolia leaf extract
  113. Socioeconomic and Behavioral Factors Leading to Acquired Bacterial Resistance to Antibiotics in Developing Countries